Symptoms of Pulmonary Fibrosis

What You Can Do To Make It Better

How Do We Define Pulmonary Fibrosis?

Breathing comes naturally to many of us. In doing so, we breathe in much needed oxygen into our bloodstream, which enables the body to work and grow. Almost every day, an average person will breathe in and out nearly 25,000 times. Now imagine having a lung disease and struggling just to do this very simple action. Pretty scary if you think about it!

One such lung disease is that of pulmonary fibrosis. Pulmonary fibrosis is a disease in which the lungs become scarred, causing the intricate passageways inside the lungs to thicken and harden. Hardening of passageways inside the lungs makes it difficult for oxygen to pass through the walls of the tiny air sacs (alveoli) into the bloodstream. The lack of oxygen in the bloodstream leaves sufferers of pulmonary fibrosis short of breath even after periods of prolonged rest. Pulmonary fibrosis is a progressive disease in which sufferers get worse over time, sometimes slowly and other times rapidly. Idiopathic pulmonary fibrosis is a form of pulmonary fibrosis that has no known cause.

Symptoms of Pulmonary Fibrosis

The symptoms of pulmonary fibrosis differ from person to person. Sometimes symptoms will progress very quickly, and other times symptoms will remain mild to moderate for years until progressing rapidly in later stages. Sufferers may experience episodes in which their symptoms suddenly worsen; these episodes are referred to as acute flare-ups of the disease. Shortness of breath is the most common complaint of pulmonary fibrosis sufferers, other symptoms include:

  • Coughing
  • Weakness
  • Fatigue
  • Achy joints
  • Weight loss

Unfortunately, the scarring that occurs from pulmonary fibrosis cannot be reversed. On top of that, no current treatment can stop the progression of the disease. Treatment for pulmonary fibrosis may include the uses of medications, oxygen therapy, surgery and pulmonary rehabilitation classes. While each treatment is basically targeted at helping relieve the conditions of the disease. Surgery is considered as the last resort as a lung transplant is required. But there is hope with treatment through the use of cellular therapy for pulmonary fibrosis.

Cellular Therapy for Pulmonary Fibrosis

In the case of pulmonary fibrosis, autologous cells are used; this means the cells come from the patient’s body. These cells are found in bone marrow or in blood (venous). Venous cells have the capacity to form many types of differentiated cells. During the procedure, cellular therapy involves isolating adult cells from bone marrow and blood requiring special laboratory techniques to collect. After extraction, the cells are isolated. At this point, the cells are returned to the patient intravenously. The minimally invasive therapy can be performed as an outpatient procedure in a clinical setting under the supervision of a professional. It takes a physician that has sought specific training to perform cellular therapy adequately, safely and successfully.

If you would like to find out more about how our treatment can relieve the symptoms of pulmonary fibrosis, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.